🎯 Background & Rationale
While bendopnoea (breathlessness induced by bending forward) is well-documented in advanced heart failure and pulmonary hypertension, its prevalence, pathophysiology, and clinical relevance have never been formally investigated in patients with pleural effusions. Although fluid drainage typically relieves dyspnoea, up to 27% of patients experience no symptomatic benefit, highlighting a gap in predicting which patients will functionally benefit most from thoracentesis or indwelling pleural catheters (IPCs). The PLEASE-3 study sought to establish bendopnoea as a novel clinical sign in pleural disease, evaluating its relationship with effusion size, diaphragmatic mechanics, and functional capacity.
👥 Study Design & Population
This is a prospective observational cohort study.
- Population: 200 unselected adult patients referred for the assessment of a pleural effusion across two tertiary centers in Australia (Sir Charles Gairdner Hospital and Westmead Hospital).
- Intervention / Exposure: Assessment of bendopnoea using a 60-second bend test (60s-BT), alongside baseline spirometry, chest radiography, and bedside ultrasound. A subset of 88 patients underwent therapeutic pleural fluid drainage (>750 mL removed) with pre- and post-drainage assessments.
- Comparison: Patients with positive bendopnoea versus those without bendopnoea; matched pre- and post-drainage cohorts.
- Outcomes: Prevalence of bendopnoea, its impact on daily activities via a structured questionnaire, correlation with radiographic effusion size, baseline 6-minute walk distance (6-MWD), visual analogue scale (VAS) dyspnoea scores, and functional changes post-drainage.
📈 Methodology & Rigor
The study employed robust prospective data collection utilizing standardized, validated assessment tools. Bendopnoea was quantified using a 60-second bend test (with post-hoc analyses at a 30-second cut-off) alongside a modified daily living impact questionnaire. Radiographic effusion size was graded independently by two reviewers using Light’s criteria. Diaphragm shape and movement were meticulously categorized via bedside ultrasonography (normal, flattened, inverted, paradoxical). Statistical rigor included Kaplan-Meier analyses, Mann-Whitney and Wilcoxon signed-rank tests for non-parametric functional outcomes, and multivariable logistic regression models controlling for key confounders like age, BMI, and underlying comorbidities.
🔬 Key Findings [or Planned Endpoints]
- Prevalence & Impact: 56% of patients tested positive for bendopnoea on the 60s-BT (median time to onset: 43 seconds; 43% tested positive within a 30-second cut-off). 74% reported that bendopnoea impacted their daily activities (e.g., putting on shoes).
- Clinical Correlates: Patients with bendopnoea had significantly higher baseline dyspnoea VAS scores (median 48 vs. 30 mm, p=0.0002) and shorter 6-MWDs (median 200 vs. 310 m, p=0.0013).
- Predictors of Bendopnoea: Multivariable analysis demonstrated that larger pleural effusion size (OR 5.08, 95% CI 1.25–20.66), abnormal/inverted/flattened ipsilateral hemidiaphragm shape (OR 3.93, 95% CI 1.32–11.68), and higher BMI (OR 1.18 per unit increase) were independently associated with baseline bendopnoea.
- Post-Drainage Outcomes: Following therapeutic drainage, the proportion of patients with bendopnoea significantly dropped from 62% to 32% (p<0.001). Crucially, patients with baseline bendopnoea experienced a significantly greater improvement in 6-MWD post-drainage compared to those without bendopnoea (median improvement of 66 m vs. 16 m, p=0.0165).
⚖️ Critical Appraisal
- Strengths: This is a first-of-its-kind, multicenter prospective study with a well-characterized cohort, rigorous standardized definitions (Light’s criteria, ultrasound diaphragmatic assessment), and objective functional endpoints (6-MWT).
- Limitations: The 60-second bend test relies on patient self-reporting, introducing potential subjective bias (Hawthorne effect). Underlying thoracic pain from pleural disease could also confound the ability or willingness to bend forward. Furthermore, the optimal post-drainage assessment window (24–72 hours) may miss delayed physiological adaptations.
- Generalizability: The cohort includes a broad, unselected mix of malignant, infectious, and transudative effusions, making the findings widely applicable to general interventional pulmonology and pleural disease clinics.
💡 The Clinical Bottom Line
Bendopnoea is an easily elicited, highly prevalent, and clinically meaningful symptom in patients with pleural effusions that correlates directly with effusion volume and diaphragmatic impairment. Clinicians should routinely screen for bendopnoea during pleural evaluations; its presence not only explains functional limitations with simple tasks like putting on shoes but also strongly signals a patient population that will achieve superior functional gains (6-minute walk distance) following therapeutic thoracentesis or IPC drainage.